Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1958 1
1960 1
1963 1
1965 1
1966 1
1969 1
1970 2
1974 2
1977 2
1982 2
1988 3
1989 2
1990 3
1992 3
1995 1
1996 1
1997 6
1998 3
1999 4
2000 7
2001 5
2002 5
2003 9
2004 13
2005 12
2006 15
2007 12
2008 30
2009 34
2010 41
2011 60
2012 90
2013 67
2014 57
2015 77
2016 49
2017 51
2018 48
2019 70
2020 49
2021 54
2022 43
2023 64
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

924 results

Results by year

Filters applied: . Clear all
Page 1
Lecanemab in Early Alzheimer's Disease.
van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. van Dyck CH, et al. Among authors: sabbagh m. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. N Engl J Med. 2023. PMID: 36449413 Clinical Trial.
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.
Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Porsteinsson AP, et al. Among authors: sabbagh mn. J Prev Alzheimers Dis. 2021;8(3):371-386. doi: 10.14283/jpad.2021.23. J Prev Alzheimers Dis. 2021. PMID: 34101796 Review.
A New Framework for Dementia Nomenclature.
Petersen RC, Weintraub S, Sabbagh M, Karlawish J, Adler CH, Dilworth-Anderson P, Frank L, Huling Hummel C, Taylor A; Dementia Nomenclature Initiative. Petersen RC, et al. Among authors: sabbagh m. JAMA Neurol. 2023 Dec 1;80(12):1364-1370. doi: 10.1001/jamaneurol.2023.3664. JAMA Neurol. 2023. PMID: 37843871 Review.
Editorial Introduction.
Sabbagh MN. Sabbagh MN. Neurol Ther. 2016 Dec;5(2):101-103. doi: 10.1007/s40120-016-0055-3. Epub 2016 Nov 9. Neurol Ther. 2016. PMID: 27830535 Free PMC article. No abstract available.
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis.
Liss JL, Seleri Assunção S, Cummings J, Atri A, Geldmacher DS, Candela SF, Devanand DP, Fillit HM, Susman J, Mintzer J, Bittner T, Brunton SA, Kerwin DR, Jackson WC, Small GW, Grossberg GT, Clevenger CK, Cotter V, Stefanacci R, Wise-Brown A, Sabbagh MN. Liss JL, et al. Among authors: sabbagh mn. J Intern Med. 2021 Aug;290(2):310-334. doi: 10.1111/joim.13244. Epub 2021 Mar 31. J Intern Med. 2021. PMID: 33458891 Free PMC article. Review.
Preface.
Al-Sabbagh M. Al-Sabbagh M. Dent Clin North Am. 2019 Jul;63(3):xiii-xv. doi: 10.1016/j.cden.2019.03.001. Epub 2019 Apr 15. Dent Clin North Am. 2019. PMID: 31097146 No abstract available.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. Among authors: sabbagh m. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
924 results